Thermo Fisher Scientific Acquires German Provider of Laboratory Water Purification Systems
Thermo Fisher Scientific Inc.y announced that it has completed the acquisition of TKA Wasseraufbereitungssysteme GmbH, a European provider of laboratory water purification systems. Based in Niederelbert, Germany, TKA has nearly 60 employees and had 2009 full year revenue of approximately €10 million.
“The addition of TKA’s comprehensive offering of laboratory water purification systems to our portfolio of laboratory equipment and consumables enables us to meet our customers’ growing needs for versatility and productivity in their laboratories,” said Thomas Loewald, president laboratory equipment of Thermo Fisher Scientific. “The demand for ultrapure water, in particular, is driven by the ever-increasing sensitivity of analytical instruments used in life science research.”
TKA’s laboratory water purification systems include electrodeionization (EDI), reverse osmosis (RO) and ultrafiltration technologies. With a wider range of laboratory water purification options, customers can match the purity-level of water to their specific requirements, increasing the reliability of results across multiple applications and improving laboratory efficiency.
The Niederelbert location will become a center for R&D and manufacturing of laboratory water purification systems and will be integrated into Thermo Fisher’s Laboratory Products and Services segment.
Most read news
Organizations
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Toxic agents behind Parkinson's disease seen at work for the first time - First look at how toxic protein clusters disrupt the membranes of healthy brain cells.
Johnson & Johnson Nordic AB Acquires Amic - Gains Access to In Vitro Diagnostic Technologies in Development for Use in Point-of-Care Settings
Agilent Technologies Announces Strategic Partnership with Pacific Laboratory Products in Australia
Domainex Ltd wins biotechnology innovation award
Sequenom Announces European Licensing Agreement With LifeCodexx
Waters to Acquire Andrew Alliance
Gold shines through properties of nano biosensors - Fluorescence in ligand-protected gold nanoclusters is an intrinsic property of the gold particles themselves
Out of REACH - New legislation threatens medicines
Neutrons for the quantum technologies of the future: breakthrough results on layered perovskites